Lakeshore Woods is one of only 2 US senior living communities offering the Apollo Health ReCODE™ Protocol a precision medicine program that addresses the root causes of Alzheimer’s. 84% of clinical trial participants improved cognitive function. Now enrolling. Limited spots remaining.
Your information is private. We will never sell it. See our Privacy Policy for how we handle your information. A real team member, not a bot, will call you.
For decades, families were told the same thing: Alzheimer’s only moves in one direction. Dr. Dale Bredesen changed that. His research identified over 36 factors — inflammation, metabolic imbalances, toxins, nutrient deficiencies, sleep dysfunction — that contribute to cognitive decline. By addressing these together using a precision medicine approach, the brain is often able to restore function.
A peer-reviewed clinical trial showed 84% of participants experienced measurable improvement in cognitive function. The 2025 randomized controlled trial found ReCODE produced an effect size 600% greater than the leading FDA-approved Alzheimer’s drug.
Published results from Apollo Health’s clinical research, including the 2025 randomized controlled trial, showed measurable cognitive improvement in many participants with mild cognitive impairment or early-stage Alzheimer’s. Every person is different — individual results vary, and no outcome can be guaranteed. A clinical assessment is required before enrollment, and this program is not a substitute for care from a licensed physician.
Every resident receives a fully personalized protocol based on their own labs, biomarkers, and cognitive assessment — not a generic program.
When Alzheimer’s began changing my brother, our family experienced the fear, confusion, and helplessness that so many families face. Doctors offered management. Nobody offered hope.
The Michigan Cognitive Recovery Center at Lakeshore Woods was built to change that. Not just to keep your loved one safe — but to give them a genuine chance at getting better, using the most rigorously researched protocol that exists today.
This is personal to me. And my team treats every family the same way.
— Steven Larsen, Founder
Published results from Apollo Health’s clinical research, including the 2025 randomized controlled trial, showed measurable cognitive improvement in many participants with mild cognitive impairment or early-stage Alzheimer’s. Every person is different — individual results vary, and no outcome can be guaranteed. A clinical assessment is required before enrollment, and this program is not a substitute for care from a licensed physician.
Every person’s cognitive decline has different root causes.
Our team reviews their situation and tells you whether ReCODE is the right fit free, no pressure, no commitment.
Your information is private. We will never sell it. See our Privacy Policy for how we handle your information. A real team member, not a bot, will call you.
Published results from Apollo Health’s clinical research, including the 2025 randomized controlled trial, showed measurable cognitive improvement in many participants with mild cognitive impairment or early-stage Alzheimer’s. Every person is different — individual results vary, and no outcome can be guaranteed. A clinical assessment is required before enrollment, and this program is not a substitute for care from a licensed physician.
The ReCODE+ program at the Michigan Cognitive Recovery Center is based on published clinical research from Apollo Health, including the 2025 randomized” controlled trial showing measurable cognitive improvement in many participants with mild cognitive impairment or early-stage Alzheimer’s. Every person is different individual results vary, and no outcome can be guaranteed. Content on this website is for general information only and is not medical advice. A clinical assessment is required before enrollment. See our Medical Disclaimer for full details.
© 2026 Goforth Group LLC d/b/a Lakeshore Woods Senior Living. All Rights Reserved.
